Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVAPOR Study: Prime-boost Anti-pneumococcal Vaccination in DLBCL
NCT04214444Phase 3Completed
- Sponsor
- University Hospital Tours
- Start
- Jul 2020
- Primary completion
- May 2024
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection (3 arms), sponsored by University Hospital Tours. Primary endpoint: Proportion of responder patients at the end of treatment. Started Jul 2020; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT04214444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04214444.